Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Applying the Framingham Risk Score for cardiovascular diseases in Jordan: A cross-sectional study

Shereen Arabiyat¹ , Odate Tadros¹, Tamara Al-Dagha¹, Deema Jaber²

¹Department of Medical Allied Sciences, Salt College, Al-Balqa Applied University, Salt; ²Biopharmaceutics and Clinical Pharmacy Department, School of Pharmacy, Zarqa University, Amman 11942, Jordan.

For correspondence:- Shereen Arabiyat Email: Shereen.arabiyat@bau.edu.jo

Accepted: 1 December 2022 Published: 29 December 2022

Citation: Arabiyat S, Tadros O, Al-Dagha T, Jaber D. Applying the Framingham Risk Score for cardiovascular diseases in Jordan: A cross-sectional study. Trop J Pharm Res 2022; 21(12):2659-2667 doi: 10.4314/tjpr.v21i12.22

© 2022 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To assess the protective measures taken by Jordanians to decrease the risk of first cardiovascular event using the Framingham Risk Score classification.

Methods: A survey was created using Google forms and disseminated through social media platforms (WhatsApp and Facebook) in order to facilitate contact with multiple sections of the Jordanian population. The questions were designed to measure the objectives of this study and a scale was used to measure the level of application. Demographic parameters were documented. Framingham’s risk score was calculated.

Results: Taking lipid-lowering medications decreased the Framingham Risk Score, and patients with significantly elevated high-density lipoprotein (HDL) values have lower Framingham Risk Scores. A significant difference in Framingham Risk Score was observed among patients with a diploma and those with high school or less education (p = 0.043). There was a significant difference in Framingham Risk Score between non-smokers and sometimes smokers.

Conclusion: The Framingham Risk Scores reveals that 90 % of individuals have a low risk of getting cardiovascular disease (CVD) in the Jordanian population, 5 % have an intermediate risk, and 5 % have a high risk. This is normal as the age range of participants in the survey was within the 20 to 30 years.

Keywords: Jordan, Framingham Risk Score, Cardiovascular disease (CVD), Risk factors, Secondary prevention